연구성과로 돌아가기
2021 연구자 정보 (136 / 1146)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Gonzalez, Maria Sarai (González, MS) |
Consultorio Doctora Maria Sarai Gonzalez Huezo, Metepec, Mexico |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Gordon, Stuart C. (Gordon, SC) |
제1저자 | Henry Ford Hlth Syst, Detroit, MI USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | |
|
Goulis, Ioannis (Goulis, I) |
Aristotle Univ Thessaloniki, Dept Internal Med 4, Gen Hosp Thessaloniki Hippokratio, Sch Med, Thessaloniki, Greece |
|
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Gulamhusein, Aliya (Gulamhusein, A) |
Toronto Gen Hosp, Toronto, ON, Canada |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Hahn, Joo-Yong (Hahn, JY) |
Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Dept Internal Med,Sch Med,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea |
AAU-7250-2020 Hahn, Joo-Yong |
|
[JCR상위 4.8] Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | myungho@chollian.net;yasuda.satoshi.hp@ncvc.go.jp; | ||
|
Harrison, Stephen (Harrison, S) |
Pinnacle Clin Res Ctr, San Antonio, TX USA Pinnacle Clin Res, San Antonio, TX USA |
GON-3283-2022 Harrison, Stephen |
|
[JCR상위 4.8] ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH [JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY |
jhamilton@arrowheadpharma.com; ychoi@cymabay.com; |
||
|
Honda, Satoshi (Honda, S) |
Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 6-1 Kishibe Shimmachi, Suita, Osaka 5648565, Japan |
GXG-5198-2022 Honda, Satoshi |
0000-0002-1393-4270 Honda, Satoshi |
[JCR상위 4.8] Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | myungho@chollian.net;yasuda.satoshi.hp@ncvc.go.jp; | ||
|
Huang, Jonathan (Huang, J) |
Univ Rochester, Rochester, NY 14627 USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Hui, Aric J. (Hui, AJ) |
Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Peoples R China |
|
|
[JCR상위 4.8] Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | jenny.yang@gilead.com; | ||
|
Hwang, Jin-Yong (Hwang, JY) |
Gyeonsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Internal Med, Sch Med, 79 Gangnam Ro, Jinju 52727, South Korea |
|
0000-0002-6632-7239 Hwang, Jin Yong |
[JCR상위 4.8] Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | myungho@chollian.net;yasuda.satoshi.hp@ncvc.go.jp; | ||
|
Idilman, Ramazan (Idilman, R) |
Ankara Univ, Dept Gastroenterol, Sch Med, Ankara, Turkey Ankara Univ, Sch Med, Gastroenterol, Ankara, Turkey |
AFL-0461-2022 Idilman, Ramazan |
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Jang, Eun Sun (Jang, ES) |
Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Coll Med, Seoul, South Korea |
|
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Janssen, Harry (Janssen, H) |
Univ Hlth Network, Toronto Western & Gen Hosp, Liver Clin, Toronto, ON, Canada |
|
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Jeong, Sook-Hyang (Jeong, SH) |
Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea |
J-5642-2012 Jeong, Sook-Hyang |
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Jeong, Young-Hoon (Jeong, YH) |
Gyeongsang Natl Univ, Dept Internal Med, Changwon Hosp, 11 Samjeongja Ro, Changwon 51472, Japan |
F-3476-2015 Jeong, Young-Hoon |
|
[JCR상위 4.8] Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | myungho@chollian.net;yasuda.satoshi.hp@ncvc.go.jp; |
페이지 이동: